|
|
||||||||
AJP - Renal Physiology, Vol 267, Issue 6 1094-F1001, Copyright © 1994 by American Physiological Society
ARTICLES |
K. Sharma and F. N. Ziyadeh
Penn Center for Molecular Studies of Kidney Diseases, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia 19104-6144.
Renal hypertrophy is an early feature of diabetes, and it may predispose the kidney to the eventual development of parenchymal dysfunction. Since we have previously demonstrated that short-term culture in high glucose concentration stimulates production of transforming growth factor-beta 1 (TGF-beta 1) in proximal tubular and glomerular mesangial cells, we postulated that this cytokine, which has potent regulatory effects on cellular growth and extracellular matrix production, is important in mediating diabetic renal disease. In this study we evaluated the gene and protein expression of TGF-beta 1 in the kidney of two rodent models of spontaneous insulin-dependent diabetes mellitus [the biobreeding (BB) rat and the nonobese diabetic (NOD) mouse]. In association with the appearance in both models of significant renal hypertrophy, TGF-beta 1 mRNA levels were increased threefold in the kidney of the diabetic BB rat after 3 days of diabetes and also threefold after 7-9 days in the NOD mouse. There was no increase in TGF-beta 1 transcripts in the livers of the diabetic animals, suggesting that this response is tissue specific. Immunohistochemical studies revealed that TGF-beta 1 protein is concordantly elevated in the cortical tubular cells of the diabetic kidney in both models. These results suggest that the stimulated expression of renal TGF-beta is an early manifestation of the involvement of the kidney by diabetes. Whether increased TGF-beta production in the diabetic kidney is a key promoter of diabetic renal manifestations (e.g., hypertrophy) deserves additional studies.
This article has been cited by other articles:
![]() |
H. M. Siragy and C. Xue Local renal aldosterone production induces inflammation and matrix formation in kidneys of diabetic rats Exp Physiol, July 1, 2008; 93(7): 817 - 824. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Way, K. Isshiki, K. Suzuma, T. Yokota, D. Zvagelsky, F. J. Schoen, G. E. Sandusky, P. A. Pechous, C. J. Vlahos, H. Wakasaki, et al. Expression of Connective Tissue Growth Factor Is Increased in Injured Myocardium Associated With Protein Kinase C {beta}2 Activation and Diabetes Diabetes, September 1, 2002; 51(9): 2709 - 2718. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Dahly, K. M. Hoagland, A. K. Flasch, S. Jha, S. R. Ledbetter, and R. J. Roman Antihypertensive effects of chronic anti-TGF-beta antibody therapy in Dahl S rats Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2002; 283(3): R757 - R767. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-L. Zhang, C. To, X. Chen, J. G. Filep, S.-S. Tang, J. R. Ingelfinger, and J. S. D. Chan Essential Role(s) of the Intrarenal Renin-Angiotensin System in Transforming Growth Factor-{beta}1 Gene Expression and Induction of Hypertrophy of Rat Kidney Proximal Tubular Cells in High Glucose J. Am. Soc. Nephrol., February 1, 2002; 13(2): 302 - 312. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Won Hong, M. Isono, S. Chen, M. C. Iglesias-de la Cruz, D. C. Han, and F. N. Ziyadeh Increased Glomerular and Tubular Expression of Transforming Growth Factor-{beta}1, Its Type II Receptor, and Activation of the Smad Signaling Pathway in the db/db Mouse Am. J. Pathol., May 1, 2001; 158(5): 1653 - 1663. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. WEIGERT, U. SAUER, K. BRODBECK, A. PFEIFFER, H. U. HÄRING, and E. D. SCHLEICHER AP-1 Proteins Mediate Hyperglycemia-Induced Activation of the Human TGF-{beta}1 Promoter in Mesangial Cells J. Am. Soc. Nephrol., November 1, 2000; 11(11): 2007 - 2016. [Abstract] [Full Text] |
||||
![]() |
A.O. Phillips Diabetic nephropathy--where next? QJM, October 1, 2000; 93(10): 643 - 646. [Full Text] [PDF] |
||||
![]() |
D. C. Han, B. B. Hoffman, S. W. Hong, J. Guo, and F. N. Ziyadeh Therapy with antisense TGF-beta 1 oligodeoxynucleotides reduces kidney weight and matrix mRNAs in diabetic mice Am J Physiol Renal Physiol, April 1, 2000; 278(4): F628 - F634. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. KOYA, M. HANEDA, H. NAKAGAWA, K. ISSHIKI, H. SATO, S. MAEDA, T. SUGIMOTO, H. YASUDA, A. KASHIWAGI, D. K. WAYS, et al. Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC {beta} inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes FASEB J, March 1, 2000; 14(3): 439 - 447. [Abstract] [Full Text] |
||||
![]() |
R. E. Gilbert, J. R. Rumble, Z. Cao, A. J. Cox, P. van Eeden, T. J. Allen, D. J. Kelly, and M. E. Cooper Endothelin Receptor Antagonism Ameliorates Mast Cell Infiltration, Vascular Hypertrophy, and Epidermal Growth Factor Expression in Experimental Diabetes Circ. Res., February 4, 2000; 86(2): 158 - 165. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. L. RISER, M. DENICHILO, P. CORTES, C. BAKER, J. M. GRONDIN, J. YEE, and R. G. NARINS Regulation of Connective Tissue Growth Factor Activity in Cultured Rat Mesangial Cells and Its Expression in Experimental Diabetic Glomerulosclerosis J. Am. Soc. Nephrol., January 1, 2000; 11(1): 25 - 38. [Abstract] [Full Text] |
||||
![]() |
C. I.-D. L. Cruz, P. Ruiz-Torres, R. G. del Moral, M. Rodriguez-Puyol, and D. Rodriguez-Puyol Age-related progressive renal fibrosis in rats and its prevention with ACE inhibitors and taurine Am J Physiol Renal Physiol, January 1, 2000; 278(1): F122 - F129. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. HAN, M. ISONO, B. B. HOFFMAN, and F. N. ZIYADEH High Glucose Stimulates Proliferation and Collagen Type I Synthesis in Renal Cortical Fibroblasts: Mediation by Autocrine Activation ofTGF-{beta} J. Am. Soc. Nephrol., September 1, 1999; 10(9): 1891 - 1899. [Abstract] [Full Text] |
||||
![]() |
F. J. KELLY, S. ANDERSON, M. M. THOMPSON, T. T. OYAMA, T. M. KENNEFICK, C. L. CORLESS, R. J. ROMAN, L. KURTZBERG, B. M. PRATT, and S. R. LEDBETTER Acute and Chronic Renal Effects of Recombinant Human TGF-{beta}2 in the Rat J. Am. Soc. Nephrol., June 1, 1999; 10(6): 1264 - 1273. [Abstract] [Full Text] |
||||
![]() |
K. Sharma, L. Wang, Y. Zhu, A. DeGuzman, G.-Y. Cao, R. B. Lynn, and S. K. Joseph Renal type I inositol 1,4,5-trisphosphate receptor is reduced in streptozotocin-induced diabetic rats and mice Am J Physiol Renal Physiol, January 1, 1999; 276(1): F54 - F61. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mogyorosi and F. N. Ziyadeh Increased decorin mRNA in diabetic mouse kidney and in mesangial and tubular cells cultured in high glucose Am J Physiol Renal Physiol, November 1, 1998; 275(5): F827 - F832. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Wang, Y. Zhu, and K. Sharma Transforming Growth Factor-beta 1 Stimulates Protein Kinase A in Mesangial Cells J. Biol. Chem., April 3, 1998; 273(14): 8522 - 8527. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Wakasaki, D. Koya, F. J. Schoen, M. R. Jirousek, D. K. Ways, B. D. Hoit, R. A. Walsh, and G. L. King Targeted overexpression of protein kinase C beta 2 isoform in myocardium causes cardiomyopathy PNAS, August 19, 1997; 94(17): 9320 - 9325. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Sharma, L. Wang, Y. Zhu, S. Bokkala, and S. K. Joseph Transforming Growth Factor-beta 1 Inhibits Type I Inositol 1,4,5-Trisphosphate Receptor Expression and Enhances Its Phosphorylation in Mesangial Cells J. Biol. Chem., June 6, 1997; 272(23): 14617 - 14623. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. N. Ziyadeh, B. B. Hoffman, D. C. Han, M. C. Iglesias-de la Cruz, S. W. Hong, M. Isono, S. Chen, T. A. McGowan, and K. Sharma Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice PNAS, July 5, 2000; 97(14): 8015 - 8020. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |